Key result
Multifunctional, healing-responsive biomaterials optimize vascular healing and endothelial recovery after PCI.
Why the study?
PCI creates a dynamic blood-material-tissue interface where thrombosis, inflammation, smooth muscle cell proliferation, and endothelial recovery evolve simultaneously. This narrative review provides a healing-centered translational framework linking coronary biomaterial properties to cellular responses, tissue healing, and clinical outcomes.
This narrative review highlights that advancing vascular healing after percutaneous coronary intervention requires multifunctional, healing-responsive biomaterial platforms evaluated by both structural coverage and functional endothelial recovery rather than assuming class-wide superiority.
Answers are grounded in this paper and cite their sources.
May inform stent biomaterial selection; leaves open prospective validation of the healing framework for outcomes.
Percutaneous coronary intervention (PCI) creates a dynamic blood–material–tissue interface in which thrombosis, inflammation, smooth muscle cell proliferation, and endothelial recovery evolve simultaneously. This narrative review examines coronary biomaterials using a healing-centered translational framework that links material properties to molecular and cellular responses, tissue-level healing, measurable structural and functional phenotypes, and clinical outcomes. We review the evolution from bare-metal and drug-eluting stents to polymer-free systems, drug-coated balloons (DCBs), bioresorbable scaffolds, and bioactive or biomimetic surfaces. Particular emphasis is placed on strut geometry, polymer chemistry and degradation, drug-release kinetics, surface properties, corrosion behavior, endothelial barrier function, macrophage responses, thrombogenicity, and neointimal growth. Structural coverage on intravascular imaging is distinguished from functional endothelial recovery, which requires complementary biological or physiological assessment. Randomized evidence is interpreted at the level of the tested device, formulation, lesion, and procedural strategy; newer platforms are not assumed to confer class-wide superiority. Future progress will require multifunctional, healing-responsive platforms that integrate antithrombotic, pro-endothelial, immunomodulatory, and controlled-delivery functions while demonstrating mechanical durability, comparative clinical effectiveness, manufacturability, and cost-effective scalability.
No takes yet. Share an insight, caveat, or question.
Bae et al. (2026) conducted a review in Patients undergoing percutaneous coronary intervention (PCI). Functional coronary biomaterials (drug-eluting stents, polymer-free systems, drug-coated balloons, bioresorbable scaffolds, and bioactive/biomimetic surfaces) was evaluated on Vascular healing, endothelial recovery, and clinical outcomes after PCI. Coronary biomaterials require multifunctional, healing-responsive designs integrating antithrombotic and pro-endothelial properties to optimize vascular healing after PCI.
Synapse has enriched 10 related papers. Consider them for comparative context: